We're gearing up for the @oncologyCOA meeting. In addition to the main events, stop by Booth 313 or reach out to learn more about how OneOncology is enabling physician independence. https://t.co/izvcj0W7NH
Phil Watts at #AMCCBS: We've seen rising costs in cancer care, which puts presssure on community practices. Given these changes, practices often ask questions about remaining independent.
Phil Watts at #AMCCBS: "At the core, a lot of community oncologists are asking, how do I remain independent yet continue to provide the highest quality care and navigate a complex heathcare environment?"
Phil Watts at #AMCCBS: We've had a groups wanting to exit hosptial aggrements and looking to groups like ours with good economies of scale and capital.
CVS reports in its annual report that if pharma companies stop sales to multiple #340B contract pharmacies it "could materially & adversely affect the Company." CVS Health is saying that 340B is an important part of earnings. So, their profits are discounts patients don't see. ??
Dr. Schleicher, Pres, TN @OSSatACCC & @tnmed member, describes 3 of 400 cases of patient steerage by PBMs away from TO’s pharmacy & often to a PBM-owned pharmacy leading to negative patient consequences. Cases contrast PBM reform bill the TN legislature passed last year.
In Growth Spurt Since Joining OneOncology, The Center in Fort Worth has grown its phyisicans on staff by 60 percent in one year. https://t.co/DNnVjwGMWU
OneOncology statement regarding Dr. Axel Grothey:
While Dr. Grothey is not a OneOncology employee, what we’ve recently learned regarding his actions at the Mayo Clinic does not align with our values and the Code of Conduct to which we hold our employees and contractors.
Leading New Jersey oncologists form Astera Cancer Care and join the OneOncology platform, making this premier group the 9th practice to join the partnership of independent community oncologists.
https://t.co/OiIGNCRvaj
"The cost of medications are going through the roof and if we as providers don’t embrace the few opportunities where we can bend the cost curve, we are going to bankrupt the system and that’s not good for anyone." #biosimilars#oncology
https://t.co/MKJHVh20pE
This partnership means that more patients in @OneOncology’s vast community network can access our genomic profiling technology and identify the insights that can inform their specific #cancer. So excited to get started!
Welcome! Los Angeles Cancer Network is joining the OneOncology partnership connecting their 18 providers with the 470 other physicians and providers on our platform from Los Angeles to New York. https://t.co/vBr07TivxH
Welcome, Dr. John Fox! We're proud that John Fox, MD has joined OneOncology as Medical Director of Managed Care. Dr. Fox will play an integral role supporting partner practices to develop and optimize value-based care to achieve Quadruple AIM goals. https://t.co/Z099lKYvHR